Weaver Consulting Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Weaver Consulting Group's ABBV Position: Q2 2026 in Review
Weaver Consulting Group increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $5.16K and bringing the position to 1,228 shares worth $309K. The position accounts for 0.06% of the portfolio, ranked #222.
Weaver Consulting Group first reported a position in ABBV in Q1 2019 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Weaver Consulting Group held 1,228 shares of AbbVie worth $309K as of Q2 2026.
- Weaver Consulting Group bought 24 AbbVie shares in Q2 2026, an estimated $5.16K.
- AbbVie made up 0.06% of Weaver Consulting Group's portfolio in Q2 2026, its #222 holding.
- Weaver Consulting Group first reported a position in AbbVie in Q1 2019 and has held it in 19 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Weaver Consulting Group's 13F filing for Q2 2026, filed 29 Jul 2026.